National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7)

The summary for the National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7): Purpose. This FOA issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, is a limited competition solicitation intended to continue operations support under the UC7 mechanism for Biosafety Level 4 (BSL4) facilities at the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will serve as a national resource for efforts in conducting clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs Biodefense Research Agenda (http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/about/pages/strategicplan.aspx) and other infectious diseases. Mechanism of Support. This FOA will utilize the UC7 award mechanism. Funds Available and Anticipated Number of Awards. The NIAID intends to commit up to $30 million in total costs annually in Fiscal Years 2011-2016 to fund the NBLs.

Federal Grant Title:	National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-10-018
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.856
CFDA Descriptions:	Microbiology and Infectious Diseases Research
Current Application Deadline:	Jul 13, 2010
Original Application Deadline:	Jul 13, 2010
Posted Date:	Jun 10, 2010
Creation Date:	Jun 10, 2010
Archive Date:	Aug 13, 2010
Total Program Funding:	$30,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: The University of Texas Medical Branch at Galveston, TX Boston University, Boston, MA
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Biomedical Prevention of HIV Research Education (R25); • Partnerships for Next Generation Biodefense Diagnostics (R01); • Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pat...; • International Extramural Associates Research Development Awards (IEARDA) [G11]; • Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03); • Non-Antibiotic Selectable Markers for Biodefense (R21); • Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Asso...; • Cooperative Research Partnerships for Biodefense (U01)
More Grants from the National Institutes of Health: • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...; • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...; • Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/...; • Biomedical Research Facilities (C06 Clinical Trial Not Allowed); • Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the ...